Jahangeer M. Malik
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 25, 2025
Astellas article: UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinoma.
Journal: The oncologist
Published: April 07, 2025
Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC).
Journal: ESMO real world data and digital oncology
Published: March 11, 2024
Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre.
Journal: Cancer medicine
Published: September 07, 2022
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).
Journal: British journal of cancer
Published: March 14, 2022
Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 28, 2021
Challenging presentations of germ cell tumours in routine clinical practice.
Journal: The journal of the Royal College of Physicians of Edinburgh
Published: April 20, 2021
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 02, 2021
Testicular cancer: improving outcomes with national quality performance indicators.
Journal: BMJ open quality
Published: May 15, 2019
The Importance of Prostate-specific Antigen (PSA) Nadir and Early Identification of PSA Relapse after 10 Years of Prostate Iodine 125 Seed Brachytherapy in Edinburgh.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: November 28, 2014
Patient-reported outcomes and health-related quality of life in prostate cancer treated with a single fraction of high dose rate brachytherapy combined with hypofractionated external beam radiotherapy.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: December 17, 2013
Last Updated: 09/26/2026